MG
OPTN

Michael Gelband’s OptiNose OPTN Stock Holding History

Michael Gelband’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-898
Closed -$26K – 2144
2023
Q1 		$26K Buy
+898
New +$23.9K ﹤0.01% 1686
2021
Q3 		– Sell
-3,063
Closed -$143K – 2493
2021
Q2 		$143K Buy
+3,063
New +$156K ﹤0.01% 2072
2021
Q1 		– Sell
-3,767
Closed -$234K – 2470
2020
Q4 		$234K Buy
+3,767
New +$231K ﹤0.01% 1653
2019
Q4 		– Sell
-733
Closed -$77K – 1790
2019
Q3 		$77K Buy
+733
New +$73.2K ﹤0.01% 1253

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Michael Gelband's OPTN Position: Q2 2023 in Review

Michael Gelband sold out of OptiNose (OPTN) in Q2 2023, closing a stake of 898 shares — an estimated $26K sold.

Michael Gelband first reported a position in OPTN in Q3 2019 and held it in 4 quarters. The position peaked at $234K in Q4 2020. 61 funds tracked by Wall St. Rank hold OPTN as of Q2 2023.

  • Michael Gelband reported no remaining OptiNose position as of Q2 2023 after selling out during the quarter.
  • Michael Gelband sold 898 OptiNose shares in Q2 2023, an estimated $26K.
  • Michael Gelband first reported a position in OptiNose in Q3 2019 and held it in 4 quarters.
  • Michael Gelband's OptiNose position peaked at $234K in Q4 2020.
  • 61 funds tracked by Wall St. Rank held OptiNose as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.